U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07195396) titled 'To Collect Enriched Human Serum Following Hydrolyzed Collagen Intake' on Sept. 12.
Brief Summary: This randomized, double-blind, monocentric, five-way cross-over study aims to collect human serum and plasma samples at 1 and 2 hours after ingestion of hydrolyzed collagen peptides. The enriched sera will be used for ex vivo/ in vitro experiments on skin keratinocytes, fibroblasts, and other cell types to explore the beneficial effects of bioactive collagen peptides. Blood will also be analyzed for amino acid profiles and collagen-derived peptides.
Study Start Date: Sept. 29
Study Type: INTERVENTIONAL
Condition:
Healthy Women
Int...